A one-stop-shop for advanced therapies

Sometimes tackling major challenges requires a major response. In the case of the Center for Breakthrough Medicines (CBM), that has meant building the world’s largest single-site CDMO dedicated to end-to-end development and manufacturing for cell and gene therapies.

In January 2020, the newly formed CBM announced its intention to build a behemoth 680,000-square foot facility inside the 1.6-million square foot Discovery Labs life science campus, a innovation hub dedicated to supporting development and manufacturing of advanced therapies based in King of Prussia, Pennsylvania. In its announcement, the company said that the $1.1 billion undertaking was aimed at addressing the “critical lack of capacity that is preventing patients from accessing critically needed cell and gene therapies.”

Read full story

Share with a Friend
Recent Press
Menu